{"PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "OtherAbstract": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "PMID": "15631089", "DateCompleted": {"Year": "2005", "Month": "05", "Day": "12"}, "DateRevised": {"Year": "2022", "Month": "03", "Day": "16"}, "Article": {"ArticleDate": [], "Language": ["chi"], "ELocationID": [], "Journal": {"ISSN": "1001-5302", "JournalIssue": {"Volume": "29", "Issue": "10", "PubDate": {"Year": "2004", "Month": "Oct"}}, "Title": "Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica", "ISOAbbreviation": "Zhongguo Zhong Yao Za Zhi"}, "ArticleTitle": "[Endothelium-independent vasorelaxant effect of puerarin on rat thoracic aorta].", "Pagination": {"StartPage": "981", "EndPage": "984", "MedlinePgn": "981-4"}, "Abstract": {"AbstractText": ["To investigate the vasorelaxant effect of puerarin in rat aortic rings and the mechanism.", "The isolated thoracic aortic rings of male Sprague-Dawley rats were mounted on the organ bath and the contractile responses of the vessel were recorded.", "Puerarin completely relaxed the contractions induced by phenylephrine in a concentration-dependent manner in endothelium-intact and endothelium-denuded rat aorta, but it had no effect on those preconstricted by a high concentration of potassium chloride (KCl, 60 mmol x L(-1)). The relaxant effect of puerarin was significantly inhibited by pretreatment of endothelium-denuded aorta with potassium channel antagonists tetraethylammonium, 4-aminopyridine but not glibenclamide.", "Puerarin induces an endothelium-independent relaxation in rat aortic rings. The mechanisms may involve the reduction in Ca2+ influx through the calcium channels operated by alpha-adrenergic receptor and the activation of the potassium channels (Kv and BKca, but not KATP)."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Cardiovascular, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China. dongkan76@sohu.com"}], "Identifier": [], "LastName": "Dong", "ForeName": "Kan", "Initials": "K"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Tao", "ForeName": "Qian-min", "Initials": "QM"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Xia", "ForeName": "Qiang", "Initials": "Q"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Shan", "ForeName": "Qi-xian", "Initials": "QX"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Pan", "ForeName": "Guo-biao", "Initials": "GB"}], "PublicationTypeList": ["English Abstract", "Journal Article"]}, "MedlineJournalInfo": {"Country": "China", "MedlineTA": "Zhongguo Zhong Yao Za Zhi", "NlmUniqueID": "8913656", "ISSNLinking": "1001-5302"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Isoflavones"}, {"RegistryNumber": "0", "NameOfSubstance": "Potassium Channel Blockers"}, {"RegistryNumber": "0", "NameOfSubstance": "Potassium Channels"}, {"RegistryNumber": "0", "NameOfSubstance": "Vasodilator Agents"}, {"RegistryNumber": "1WS297W6MV", "NameOfSubstance": "Phenylephrine"}, {"RegistryNumber": "66-40-0", "NameOfSubstance": "Tetraethylammonium"}, {"RegistryNumber": "BH3B64OKL9", "NameOfSubstance": "4-Aminopyridine"}, {"RegistryNumber": "Z9W8997416", "NameOfSubstance": "puerarin"}], "MeshHeadingList": [{"QualifierName": ["pharmacology"], "DescriptorName": "4-Aminopyridine"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["drug effects", "physiology"], "DescriptorName": "Aorta, Thoracic"}, {"QualifierName": ["physiology"], "DescriptorName": "Endothelium, Vascular"}, {"QualifierName": [], "DescriptorName": "In Vitro Techniques"}, {"QualifierName": ["isolation & purification", "pharmacology"], "DescriptorName": "Isoflavones"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": ["antagonists & inhibitors"], "DescriptorName": "Phenylephrine"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Potassium Channel Blockers"}, {"QualifierName": ["drug effects"], "DescriptorName": "Potassium Channels"}, {"QualifierName": ["chemistry"], "DescriptorName": "Pueraria"}, {"QualifierName": [], "DescriptorName": "Rats"}, {"QualifierName": [], "DescriptorName": "Rats, Sprague-Dawley"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Tetraethylammonium"}, {"QualifierName": ["drug effects"], "DescriptorName": "Vasoconstriction"}, {"QualifierName": ["drug effects"], "DescriptorName": "Vasodilation"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Vasodilator Agents"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2005", "Month": "1", "Day": "6", "Hour": "9", "Minute": "0"}, {"Year": "2005", "Month": "5", "Day": "13", "Hour": "9", "Minute": "0"}, {"Year": "2005", "Month": "1", "Day": "6", "Hour": "9", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["15631089"]}}], "PubmedBookArticle": []}